Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02407743 · ClinicalTrials.gov registry record
TEMporal PostOperative Pain Signatures
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 428
- Enrollment target
NCT02407743: Completed study, sponsored by University of Florida.
NCT02407743 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 428 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02407743 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 428 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine what causes pain after surgery to increase or decrease over time.
Primary Outcome
Pain scores will be measured using previously established pain scale and Questionnaire
Interventions
- BEHAVIORAL Surgical patients' clinical progression
- GENETIC Genetic markers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 428 participants |
| Start Date | 2015-08 |
| Est. Completion | 2020-08 |
What the finished NCT02407743 record still lists
NCT02407743 is an observational study that tracks outcomes without assigning an intervention. The registered 428 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Surgical patients' clinical progression is the first listed.
NCT02407743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02407743 about?
NCT02407743 is a clinical study titled "TEMporal PostOperative Pain Signatures". The purpose of this research study is to determine what causes pain after surgery to increase or decrease over time.
What is the current status of trial NCT02407743?
This trial is currently completed. The enrollment target is 428 participants. The study started on 2015-08. Estimated completion is 2020-08.
What interventions are being tested in trial NCT02407743?
The interventions under investigation include: Surgical patients' clinical progression (BEHAVIORAL), Genetic markers (GENETIC).
Who is sponsoring clinical trial NCT02407743?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia